Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : YEEHAW CANDIDATES -- Ignore unavailable to you. Want to Upgrade?

To: Ken W who wrote (1670)	4/8/2003 9:35:01 PM
From: JoeinIowa	Respond to of 23958

Ken, A little more detail on IDEV. Their website has some pretty good detail on what they are up to. interneuron.com They have three drugs that are in the Phase III area. The one that is currently generating the interest is Trospium which is for Bladder control. They had a successful outcome that they reported back in December and now will report at the end of the month at the Ureology Convention. Several others have potential to generate some excitement but right now I think the stock will move with the meeting at the end of the month and the NDA they plan to submit in this quarter. On the fundamental side they burn about $6M/quarter and have $36M in the bank and no debt. They do seem to like to partner with larger companies which may help them out. Speculation is they might be partnering on Trospium in the near future. I ended up not waiting for the gap fill and bought in today. See where it leads up till the end of the month. Is that a long term hold in this market? Joe